22 March 2022 | News
The pharmaceutical sector contributes to 5% of Singapore’s GDP with a possible potential for growth as we look ahead to prepare better for future pandemics
Around 400 of Asia’s renowned Biopharmaceutical manufacturing and logistics leadership personnel will gather in-person at the Biomanufacturing and BioLogistics conferences from 29th to 31st March 2022.
Exhibiting at Suntec Singapore, this will be the 9th Annual BioManufacturing World Asia and 6th Annual BioLogistics World Asia summits - the largest of such events till date.
With significant opportunities abounding in biologics manufacturing and vaccine development, key challenges in cell therapy manufacture, pathogen safety, costreduction in downstream processing, single-use technologies are crucial points of interest and will be unpacked by those most qualified to talk about them.
Presentations on the latest manufacturing technologies, and exhibitions of the leading solutions available to bioprocessing businesses, will take centre stage.
Alongside the conferences, the Asia-Pacific Bioprocessing Excellence Awards will be presented. This award seeks to give recognition to exceptional bioprocessing experts, organisations and technologies that facilitate biomanufacturing and biologistics excellence at enhanced speed, reduced cost, and superior quality.
The event is organised and helmed by IMAPAC, a home-grown Singaporean firm that acts as a biopharma communication agency to the industry and uplifts the research and commercial arms of biopharma in Asia.